Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia

Verghese Mathew, Charles R. Cannan, Virginia M Miller, Dustan A. Barber, David Hasdai, Robert S. Schwartz, David Holmes, Amir Lerman

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Background: Experimental hypercholesterolemia is associated with coronary vasomotor dysfunction. This study was designed to test the hypothesis that experimental hypercholesterolemia is characterized by altered coronary vasomotor responses to endothelin and inhibition of the endogenous NO pathway. Methods and Results: Endothelin-1 (ET-1) at 5 ng · kg-1 · min-1 or N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthase (NOS), at 50 μg · kg-1 · min-1 was infused into the left anterior descending coronary artery in pigs before and after 10 weeks of cholesterol diet. There was a significant increase in serum cholesterol. At 10 weeks, ET-1 resulted in an accentuated decrease in coronary blood flow (CBF) and coronary artery diameter (CAD) compared with baseline (-88±6% versus -45±9%, P<.05, and -77±14% versus -18±8%, P<.05, respectively) and an increase in Coronary vascular resistance (CVR) (242±18% versus 110±17%, P<.05); ET receptor density and binding affinity in epicardial coronary arteries were unchanged. The effect of L-NMMA on CBF, CAD, and CVR was attenuated at 10 weeks (-7±8% versus -48±4%, -2±3% versus -17±5%, and 16±10% versus 125±32%; each P<.05). Immunohistochemistry staining for constitutive NOS revealed a decrease in immunoreactivity in the coronary arteries of hypercholesterolemic pigs. Conclusions: The present study demonstrates an enhanced coronary vasoconstrictive response to pathophysiological doses of endothelin and an attenuated response to the inhibition of endogenous NO activity, suggesting an alteration in coronary vascular reactivity in experimental hypercholesterolemia.

Original languageEnglish (US)
Pages (from-to)1930-1936
Number of pages7
JournalCirculation
Volume96
Issue number6
StatePublished - Sep 16 1997

Fingerprint

Endothelins
Hypercholesterolemia
Vasoconstriction
Coronary Vessels
Nitric Oxide
omega-N-Methylarginine
Endothelin-1
Nitric Oxide Synthase
Vascular Resistance
Swine
Cholesterol
Blood Vessels
Arginine
Immunohistochemistry
Staining and Labeling
Diet
Serum

Keywords

  • Circulation
  • Endothelin
  • Endothelium-derived factors
  • Hypercholesterolemia

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. / Mathew, Verghese; Cannan, Charles R.; Miller, Virginia M; Barber, Dustan A.; Hasdai, David; Schwartz, Robert S.; Holmes, David; Lerman, Amir.

In: Circulation, Vol. 96, No. 6, 16.09.1997, p. 1930-1936.

Research output: Contribution to journalArticle

Mathew, Verghese ; Cannan, Charles R. ; Miller, Virginia M ; Barber, Dustan A. ; Hasdai, David ; Schwartz, Robert S. ; Holmes, David ; Lerman, Amir. / Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. In: Circulation. 1997 ; Vol. 96, No. 6. pp. 1930-1936.
@article{2048f3b6617a45bcaa7ce8965707439b,
title = "Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia",
abstract = "Background: Experimental hypercholesterolemia is associated with coronary vasomotor dysfunction. This study was designed to test the hypothesis that experimental hypercholesterolemia is characterized by altered coronary vasomotor responses to endothelin and inhibition of the endogenous NO pathway. Methods and Results: Endothelin-1 (ET-1) at 5 ng · kg-1 · min-1 or N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthase (NOS), at 50 μg · kg-1 · min-1 was infused into the left anterior descending coronary artery in pigs before and after 10 weeks of cholesterol diet. There was a significant increase in serum cholesterol. At 10 weeks, ET-1 resulted in an accentuated decrease in coronary blood flow (CBF) and coronary artery diameter (CAD) compared with baseline (-88±6{\%} versus -45±9{\%}, P<.05, and -77±14{\%} versus -18±8{\%}, P<.05, respectively) and an increase in Coronary vascular resistance (CVR) (242±18{\%} versus 110±17{\%}, P<.05); ET receptor density and binding affinity in epicardial coronary arteries were unchanged. The effect of L-NMMA on CBF, CAD, and CVR was attenuated at 10 weeks (-7±8{\%} versus -48±4{\%}, -2±3{\%} versus -17±5{\%}, and 16±10{\%} versus 125±32{\%}; each P<.05). Immunohistochemistry staining for constitutive NOS revealed a decrease in immunoreactivity in the coronary arteries of hypercholesterolemic pigs. Conclusions: The present study demonstrates an enhanced coronary vasoconstrictive response to pathophysiological doses of endothelin and an attenuated response to the inhibition of endogenous NO activity, suggesting an alteration in coronary vascular reactivity in experimental hypercholesterolemia.",
keywords = "Circulation, Endothelin, Endothelium-derived factors, Hypercholesterolemia",
author = "Verghese Mathew and Cannan, {Charles R.} and Miller, {Virginia M} and Barber, {Dustan A.} and David Hasdai and Schwartz, {Robert S.} and David Holmes and Amir Lerman",
year = "1997",
month = "9",
day = "16",
language = "English (US)",
volume = "96",
pages = "1930--1936",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia

AU - Mathew, Verghese

AU - Cannan, Charles R.

AU - Miller, Virginia M

AU - Barber, Dustan A.

AU - Hasdai, David

AU - Schwartz, Robert S.

AU - Holmes, David

AU - Lerman, Amir

PY - 1997/9/16

Y1 - 1997/9/16

N2 - Background: Experimental hypercholesterolemia is associated with coronary vasomotor dysfunction. This study was designed to test the hypothesis that experimental hypercholesterolemia is characterized by altered coronary vasomotor responses to endothelin and inhibition of the endogenous NO pathway. Methods and Results: Endothelin-1 (ET-1) at 5 ng · kg-1 · min-1 or N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthase (NOS), at 50 μg · kg-1 · min-1 was infused into the left anterior descending coronary artery in pigs before and after 10 weeks of cholesterol diet. There was a significant increase in serum cholesterol. At 10 weeks, ET-1 resulted in an accentuated decrease in coronary blood flow (CBF) and coronary artery diameter (CAD) compared with baseline (-88±6% versus -45±9%, P<.05, and -77±14% versus -18±8%, P<.05, respectively) and an increase in Coronary vascular resistance (CVR) (242±18% versus 110±17%, P<.05); ET receptor density and binding affinity in epicardial coronary arteries were unchanged. The effect of L-NMMA on CBF, CAD, and CVR was attenuated at 10 weeks (-7±8% versus -48±4%, -2±3% versus -17±5%, and 16±10% versus 125±32%; each P<.05). Immunohistochemistry staining for constitutive NOS revealed a decrease in immunoreactivity in the coronary arteries of hypercholesterolemic pigs. Conclusions: The present study demonstrates an enhanced coronary vasoconstrictive response to pathophysiological doses of endothelin and an attenuated response to the inhibition of endogenous NO activity, suggesting an alteration in coronary vascular reactivity in experimental hypercholesterolemia.

AB - Background: Experimental hypercholesterolemia is associated with coronary vasomotor dysfunction. This study was designed to test the hypothesis that experimental hypercholesterolemia is characterized by altered coronary vasomotor responses to endothelin and inhibition of the endogenous NO pathway. Methods and Results: Endothelin-1 (ET-1) at 5 ng · kg-1 · min-1 or N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthase (NOS), at 50 μg · kg-1 · min-1 was infused into the left anterior descending coronary artery in pigs before and after 10 weeks of cholesterol diet. There was a significant increase in serum cholesterol. At 10 weeks, ET-1 resulted in an accentuated decrease in coronary blood flow (CBF) and coronary artery diameter (CAD) compared with baseline (-88±6% versus -45±9%, P<.05, and -77±14% versus -18±8%, P<.05, respectively) and an increase in Coronary vascular resistance (CVR) (242±18% versus 110±17%, P<.05); ET receptor density and binding affinity in epicardial coronary arteries were unchanged. The effect of L-NMMA on CBF, CAD, and CVR was attenuated at 10 weeks (-7±8% versus -48±4%, -2±3% versus -17±5%, and 16±10% versus 125±32%; each P<.05). Immunohistochemistry staining for constitutive NOS revealed a decrease in immunoreactivity in the coronary arteries of hypercholesterolemic pigs. Conclusions: The present study demonstrates an enhanced coronary vasoconstrictive response to pathophysiological doses of endothelin and an attenuated response to the inhibition of endogenous NO activity, suggesting an alteration in coronary vascular reactivity in experimental hypercholesterolemia.

KW - Circulation

KW - Endothelin

KW - Endothelium-derived factors

KW - Hypercholesterolemia

UR - http://www.scopus.com/inward/record.url?scp=0030823394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030823394&partnerID=8YFLogxK

M3 - Article

C2 - 9323083

AN - SCOPUS:0030823394

VL - 96

SP - 1930

EP - 1936

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -